Accrued Liabilities - Nanobiotix SA (PAR:NANO) - Alpha Spread

Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.584 EUR -1.33%
Market Cap: 217.3m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Nanobiotix SA
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nanobiotix SA
Accrued Liabilities Peer Comparison

Comparables:
VLA
IPH
GNFT
ALERS
OSE

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Nanobiotix SA
PAR:NANO
Accrued Liabilities
€7.4m
CAGR 3-Years
4%
CAGR 5-Years
110%
CAGR 10-Years
23%
Valneva SE
PAR:VLA
Accrued Liabilities
€41.5m
CAGR 3-Years
50%
CAGR 5-Years
36%
CAGR 10-Years
26%
Innate Pharma SA
PAR:IPH
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genfit SA
NASDAQ:GNFT
Accrued Liabilities
€4.2m
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Accrued Liabilities
€6.1m
CAGR 3-Years
5%
CAGR 5-Years
20%
CAGR 10-Years
6%
OSE Immunotherapeutics SA
PAR:OSE
Accrued Liabilities
€1.9m
CAGR 3-Years
-4%
CAGR 5-Years
9%
CAGR 10-Years
N/A

See Also

What is Nanobiotix SA's Accrued Liabilities?
Accrued Liabilities
7.4m EUR

Based on the financial report for Dec 31, 2023, Nanobiotix SA's Accrued Liabilities amounts to 7.4m EUR.

What is Nanobiotix SA's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
23%

Over the last year, the Accrued Liabilities growth was 12%. The average annual Accrued Liabilities growth rates for Nanobiotix SA have been 4% over the past three years , 110% over the past five years , and 23% over the past ten years .

Back to Top